2 completed, 2 recruiting. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow mycophenolate sodium: new trials by email Literature Review of mycophenolate sodium trials Research Report on mycophenolate sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin - Kidney Transplant Rejection | Phase 2 / Phase 3 | Recruiting | Sanofi | 526 | 2026-03-13 | 2026-10-13 |
| Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cyclosporine - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 60 | 2021-01-25 | 2026-05-29 |
| Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) Simulect®, Neoral®, Certican® - Renal Transplantation | Phase 2 | Completed | Novartis Pharmaceuticals | 16 | 2012-03-01 | 2014-07-25 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare Mycophenolate sodium, Prednisone, Methylprednisolone - Lupus Nephritis | Phase 2 | Completed | Novartis Pharmaceuticals | 81 | 2007-02-01 | 2011-06-28 |
Burkitt Lymphoma (1) · Hodgkin Disease (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Prolymphocytic (1) · Lupus Nephritis (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1) · Myelodysplastic Syndromes (1)
Novartis Pharmaceuticals (2) · Fred Hutchinson Cancer Center (1) · Sanofi (1)
France (3) · Hungary (2) · Italy (2) · Spain (2) · United Kingdom (2) · United States (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Chile (1) · China (1) · Colombia (1) · Czechia (1) · Denmark (1)
Phuong Vo, MD (1)
2025 (1)